GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Avricore Health Inc (OTCPK:AVCRF) » Definitions » Research & Development

AVCRF (Avricore Health) Research & Development : $0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Avricore Health Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Avricore Health's Research & Development for the three months ended in Sep. 2024 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 was $0.00 Mil.

Avricore Health Research & Development Historical Data

The historical data trend for Avricore Health's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avricore Health Research & Development Chart

Avricore Health Annual Data
Trend Jun14 Jun15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Avricore Health Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Avricore Health Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avricore Health  (OTCPK:AVCRF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Avricore Health Research & Development Related Terms

Thank you for viewing the detailed overview of Avricore Health's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Avricore Health Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Avricore Health Inc (OTCPK:AVCRF) » Definitions » Research & Development
Comparable Companies
XCNQ:VTAL TSXV:ARC TSXV:MBI.H TSXV:TELO XCNQ:IZO XCNQ:BUX TMO DHR XSWX:LONN IDXX A IQV SHSE:603259 MTD WAT NTRA LH DGX XPAR:BIM ICLR
Traded in Other Exchanges
AVCR:Canada
Address
1120 - 789 West Pender Street, Vancouver, BC, CAN, V6C 1H2
Website
https://www.avricorehealth.com
Avricore Health Inc is a Canada-based company. The company is involved in the business of health data and point-of-care technologies. The Company has only one segment, being the HealthTab - Point of Care Business in Canada. The Company's revenues are generated from operating leases of the POCT system and the sale of testing panels.